Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Pneumagen, a UK-based spinout of University of St Andrews working on a nose spray to prevent and treat respiratory infections, has obtained £2.5m ($3.4m) in an extension backed by an undisclosed corporate and unnamed, existing investors. The company raised an initial $4.9m tranche in May 2020 from Thairm Bio and Scottish Investment Bank. Pneumagen has now raised approximately £9.5m ($13m at current exchange rates) altogether, it said.
Castings Technology International, a UK-based provider of manufacturing services for cast…
